All In MedTech

Device Trial Radar · NCT01761006

Evaluation of FeNO During and Following Acute COPD Exacerbation

A Single-Center Exploratory Study to Evaluate FeNO Using the NIOX MINO® Device in COPD Patients Aged ≥40 Years During and Following Recovery From an Acute COPD Exacerbation

Last checked: Nov 19, 2026Latest source record: Nov 7, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

Terminated

Status

Terminated

Enrollment

10

Actual

Start

Mar 2013

Primary completion

Sep 23, 2014

Study completion Sep 23, 2014

Sponsor

Lead sponsor
Wake Forest UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Aerocrine AB
First posted
Jan 4, 2013

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this research study is to determine whether exhaled nitric oxide (FeNO) goes up during an acute exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD) and whether the level of exhaled nitric oxide returns to normal in the weeks after an exacerbation.

Conditions

  • Chronic Obstructive Pulmonary Disease

Interventions

  • NIOX MINO®Device

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in FeNO from Day 0 to the end of the studyTime frame: Time points for measurement of the Primary Endpoint will be between Day 0 (considered baseline) and Visit 2/Day 14, Visit 3/Day 28 and Visit 4/Day 56.

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Wake Forest University Baptist Medical Center

    Winston-Salem, North Carolina

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.